New Delhi, April 11: The Congress on Sunday attacked the Centre over its handling of the coronavirus pandemic, alleging that COVID-19 continues to wreak havoc on Indian lives and economy due to the Modi government’s “arrogance and incompetence”.
The Opposition party also alleged that every section of the society was troubled due to the policies of the government.
In an apparent dig at Prime Minister Narendra Modi, Congress leader Rahul Gandhi tweeted in Hindi, “No control over coronavirus, not enough vaccines, no employment, labourers and farmers not being given a hearing, no protection for MSMEs, nor the middle class is satisfied…It was okay to eat ‘aam’ (mango), but should have at least spared ‘aam aadmi (common person)’!”
The Congress, from its official Twitter handle, also slammed the government over the situation in the country.
“One year on, COVID-19 continues to wreak havoc upon Indian lives & the Indian Economy, all thanks to Modi govt and its arrogance & incompetence,” the party lashed out in a tweet.
In another tweet in Hindi, the party claimed that every section of the society in the country is troubled due to the policies of the government.
“Coronavirus is spreading unchecked, there is shortage of vaccines, farmers-labourers are troubled, economy is collapsing, small businesses are closing down and the middle class is also a worried lot,” the party said.
The Congress-led opposition has been criticising the government over its handling of the COVID-19 pandemic and the vaccination drive, while the Centre has maintained that its timely steps have been instrumental in effectively dealing with the pandemic.
India bans export of Remdesivir injection amid surge in Covid cases
India on Sunday banned the export of Remdesivir injection till the Covid-19 situation improves in the country.
The government in a statement said that all domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors to facilitate access to the drug.
Drugs inspectors and other officers have been directed to verify stocks & also take measures to curb hoarding & black marketing.
The Department of Pharmaceuticals has been in contact with the domestic manufacturers to ramp up the production of Remdesivir, the government said.
In a statement, the government said, “India is witnessing a recent surge in Covid cases. As of April 11, there are 11.08 lakh active Covid cases and they are steadily increasing. This has led to a sudden spike in demand for Injection Remdesivir used in the treatment of Covid patients. There is a potential of a further increase in this demand in the coming days.”
A total of seven Indian companies are producing Injection Remdesivir under a voluntary licensing agreement with Gilead Sciences in the United States of America. They have an installed capacity of about 38.80 lakh units per month, it said.
The states and UTs have been advised that the steps should again be communicated to all hospitals, both in public and private sector, and compliance monitored, the statement added.
The government has also advised the States that the extant “National Clinical Management Protocol for Covid-19”, which is based on evidence, has been developed after many interactions by the Committee of Experts, and is the guiding document for treatment of Covid-19 patients.
“In the Protocol, Remdesivir is listed as an Investigational Therapy, an example was informed and shared decision making is essential, besides taking note of contraindications mentioned in the detailed guidelines, they added.
The alarming spike in Covid cases in the country has led to a sudden increase in demand for the Remdesivir injection used in treating Covid patients. (PTI)